Blueprint Medicines Corpo... (BPMC)
106.42
3.86 (3.76%)
At close: Jan 15, 2025, 11:59 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -506.98M | -557.52M | -644.09M | 313.88M | -347.69M | -236.64M | -148.12M | -72.50M | -52.77M | -40.28M | -20.91M |
| Depreciation & Amortization | 11.66M | 11.73M | 6.48M | 6.56M | 5.26M | 4.25M | 1.58M | 1.58M | 948.00K | 622.00K | 501.00K |
| Stock-Based Compensation | 92.67M | 98.97M | 91.63M | 75.53M | 54.65M | 30.53M | 12.52M | 6.14M | 5.18M | 2.33M | 351.00K |
| Other Working Capital | -30.99M | -40.60M | 2.80M | -1.73M | -94.00K | 31.68M | 2.46M | 33.11M | 16.51M | 2.26M | 472.00K |
| Other Non-Cash Items | 6.93M | -1.70M | 269.64M | 6.22M | 4.99M | -4.39M | 32.00K | 73.00K | 109.00K | 85.00K | 26.00K |
| Deferred Income Tax | n/a | n/a | 1.36M | 466.00K | -4.95M | n/a | -320.00K | 301.00K | 445.00K | 100.00K | -4.00K |
| Change in Working Capital | -41.13M | -53.77M | -23.68M | -15.62M | 9.72M | 31.24M | 14.44M | 39.89M | 14.41M | 1.75M | 1.01M |
| Operating Cash Flow | -436.85M | -502.28M | -298.65M | 387.04M | -278.01M | -175.01M | -119.86M | -24.51M | -31.68M | -35.40M | -19.02M |
| Capital Expenditures | -16.06M | -8.92M | -261.24M | -3.16M | -14.01M | -12.68M | -15.51M | -2.35M | -4.88M | -700.00K | -257.00K |
| Acquisitions | n/a | n/a | 258.15M | 431.09M | 2.45M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -766.36M | -489.70M | -655.45M | -969.44M | -738.39M | -801.24M | -360.83M | -264.47M | -1.20M | n/a | n/a |
| Sales Maturities Of Investments | 1.06B | 349.37M | 690.83M | 538.35M | 735.93M | 652.83M | 304.00M | 48.00M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -290.00K | -258.15M | -431.09M | -2.45M | -148.41M | -3.50M | 119.00K | -1.20M | n/a | n/a |
| Investing Cash Flow | 274.04M | -149.54M | -225.86M | -434.25M | -16.47M | -161.09M | -75.85M | -218.70M | -6.08M | -700.00K | -257.00K |
| Debt Repayment | 97.93M | 137.79M | n/a | n/a | n/a | -1.53M | -2.58M | -3.33M | -1.81M | 6.25M | 3.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -44.00K | 424.02M | 50.72M | 35.27M | 13.17M | 5.98M | -965.00K | -143.00K | -2.05M | 74.83M | 14.94M |
| Financial Cash Flow | 119.22M | 561.81M | 50.72M | 617.76M | 340.64M | 4.45M | 543.95M | 132.58M | 153.22M | 81.35M | 17.99M |
| Net Cash Flow | -43.38M | -90.22M | -474.69M | 570.20M | 46.17M | -331.64M | 348.24M | -110.64M | 115.47M | 45.25M | -1.29M |
| Free Cash Flow | -452.91M | -511.20M | -559.89M | 383.88M | -292.03M | -187.69M | -135.38M | -26.87M | -36.56M | -36.10M | -19.28M |